21:30 PM

Dr. Tyler Allison with Children’s Mercy, Kansas City, MO, Recognized As Partner in MS Care By the National MS Society

A prestigious recognition, the National MS Society awards this title to a handful of healthcare providers each year


Kansas City, Missouri – On December 16, 2020, Dr. Tyler Allison, a leading provider of expert and knowledgeable care for children living with multiple sclerosis in Kansas City, Missouri, will be recognized as a Partner in MS Care through the National Multiple Sclerosis Society’s Partners in MS Care program, which recognizes and supports providers that exemplify exceptional commitment to high-quality MS care. Children’s Mercy’s clinicians continually demonstrate a wealth of knowledge, experience and the important attention to detail necessary in treating people living with MS. Dr. Tyler Allison with Children’s Mercy is the first pediatric MS Partner in MS Care in the Kansas City, Missouri, area offering enhanced care to local residents living with MS. Dr. Allison and Children’s Mercy are also an affiliate site of the Network of Pediatric MS Centers.

MS is an unpredictable, often disabling disease of the central nervous system that interrupts the flow of information within the brain, and between the brain and body, with approximately 5,000 children living with MS in the United States. Symptoms range from numbness and tingling to blindness and paralysis, and no two individuals will experience the disease in the same way. Due to the complexity of the disease, patients with MS are often a medically underserved community and finding a doctor able to treat their disease can be difficult.

To help combat this, the National MS Society created its Partners in MS Care program to call attention to committed providers, like Dr. Tyler Allison that continually offer services in alignment with the Society’s initiative of affordable access to high quality MS healthcare for everyone living with the disease – regardless of geography, disease progression, and other disparities.

“We are proud to partner with Dr. Tyler Allison with Children’s Mercy to enhance quality and dedicated care for the people who live with MS in Kansas City and surrounding community," said Jenna Washnieski, National MS Society, Mid-America. “In earning this recognition, Dr. Tyler Allison has demonstrated extraordinary leadership in MS care, making a tremendous impact on the nearly 1 million people living with MS in our country,” Washnieski continued.

To learn more about MS and the National MS Society, visit www.nationalMSsociety.org.


About Multiple Sclerosis

Multiple sclerosis is an unpredictable, often disabling disease of the central nervous system that disrupts the flow of information within the brain, and between the brain and body. Symptoms vary from person to person and range from numbness and tingling, to walking difficulties, fatigue, dizziness, pain, depression, blindness and paralysis. The progress, severity and specific symptoms of MS in any one person cannot yet be predicted, but advances in research and treatment are leading to better understanding and moving us closer to a world free of MS. Most people with MS are diagnosed between the ages of 20 and 50, with three times more women than men being diagnosed with the disease. A recent study led by the National MS Society estimates that nearly 1 million people are living with MS in the United States; twice as many than previously thought.

MS in children is not that different from MS in adults. Children with MS exclusively have a relapsing-remitting course, which means there are clear attacks (relapses) of symptoms that subside (remit). During the periods of remission between attacks, there is no progression of the disease. Even though children may experience frequent relapses (possibly more than typically seen in adults), studies have shown that children also seem to have very good recovery that is often more rapid than that of adults.

Less than 5,000 children and teens are living with MS in the United States and less than 10,000 worldwide. Diagnosing MS in children is more challenging than in adults because of other childhood disorders with similar symptoms and characteristics.

About the National Multiple Sclerosis Society

The Society mobilizes people and resources so that everyone affected by multiple sclerosis can live their best lives as we stop MS in its tracks, restore what has been lost and end MS forever. Last year, the Society invested $35 million in MS research with more than 340 active projects around the world. Through its comprehensive nationwide network of services, the Society is focused on helping those affected by MS connect to the people, information and resources needed to live their best lives. We are united in our collective power to do something about MS now and end this disease forever. Learn more at nationalMSsociety.org.

Early and ongoing treatment with an FDA-approved therapy can make a difference for people with multiple sclerosis. Learn about your options by talking to your health care professional and contacting the National MS Society at nationalMSsociety.org or 800-344-4867.



About Us

Children’s Mercy Kansas City is an independent, non-profit, 390-bed pediatric health system, providing over half a million patient encounters each year for children from across the country. Children’s Mercy is ranked by U.S. News & World Report in all ten specialties. We have received Magnet® recognition five times for excellence in nursing services. In affiliation with the University of Missouri-Kansas City, our faculty of nearly 800 pediatric specialists and researchers is actively involved in clinical care, pediatric research and educating the next generation of pediatricians and pediatric subspecialists. The Children’s Mercy Research Institute (CMRI) integrates research and clinical care with nationally recognized expertise in genomic medicine, precision therapeutics, population health, health care innovation and emerging infections. In 2021 the CMRI moved into a nine-story, 375,000-square-foot space emphasizing a translational approach to research in which clinicians and researchers work together to accelerate the pace of discovery that enhances care.